15 research outputs found
Immunoexpression of cell cycle regulators in canine prostate with proliferative lesions
Immunostaining of p21, p27, p53, cyclin D1, c-myc was evaluated in normal canine prostate and prostate with proliferative disorders to verify the interaction between these regulators of cell cycle progression. From 106 samples of canine prostate obtained from a TMA block, 15 were considered normal, 16 diagnosed as benign prostatic hyperplasia (BPH), 30 as proliferative inflammatory atrophy (PIA), 20 as prostatic intraepithelial neoplasia (PIN), and 25 as prostatic carcinoma (PC). There was positive correlation between p21 and p27 for number of stained cells and staining intensity in all conditions and between c-myc and p53 in prostates with PIN. Considering the number of labeled cells, there was positive correlation between p21 and p53 in the normal prostate. Relative to the intensity of staining, there was positive correlation between p21 and p53 in prostate tissue with PIN and between p27 and c-myc in prostates with PIA. A negative correlation between c-myc and cyclin D1 was also identified in the glands with PIN, considering the number of labeled cells, and between p27 and c-myc in the prostates with PC for staining intensity. In conclusion, the expression of p21, p27, p53, cyclin D1 and c-myc varies according to type of proliferative lesion in canine prostate. Taken together, the results indicate low growth potential of the canine PC in the presence of p21 and p27 overexpression, cyclin D1 low expression and regular expression of c-myc, even with the expression of p53 mutant type. Further, it was possible reaffirm the premalignant potential of PIA and PIN in canine prostate
Termografia infravermelho da superfície abdominal ventral de coelhos (oryctolagus cuniculus) pré e pós-laparorrafia mediana com fios de quitosana ou poliglecaprone / Infrared thermography of ventral abdominal surface of rabbits (oryctolagus cuniculus) pre and post midline laparorrhaphy using chitosan or polyglecaprone yarns
A termografia infravermelha foi utilizada para analisar inflamação, infecção ou trauma capaz de modificar o fluxo sanguíneo em uma região anatômica. Objetiva-se avaliar a temperatura superficial da parede abdominal ventral de coelhos (Oryctolagus cuniculus) pré e pós-laparorrafia com fios de quitosana, ou poliglecaprone, por termografia infravermelho. O experimento foi realizado em duas etapas. Na primeira etapa, foram utilizados sete coelhos machos e sete fêmeas. Neste período, as avaliações durante os períodos matutino e vespertino foram realizadas por dez dias consecutivos. Na segunda etapa, foram utilizados 42 coelhos, alocados em dois grupos com 21 animais cada. Um grupo foi submetido a laparorrafia mediana com sutura de quitosana e o outro com fio de Poliglecaprone 25. Nesta fase, as avaliações termográficas foram iniciadas no primeiro dia de pós-operatório e repetidas diariamente pela manhã. Na fase pré-operatória, as temperaturas da superfície abdominal variaram de 37,69 - 38,38. Em relação ao pós-operatório, notou-se diferença estatística para todas as comparações estudadas: P = 0,0035 entre a primeira e segunda etapas; P = 0,0003 entre os grupos Quitosana e Poliglecaprona. Em conclusão, a temperatura da superfície abdominal de coelhos, avaliada pelo método do infravermelho, varia entre os períodos do dia mesmo em ambiente controlado, e também diverge na reparação tecidual da laparorrafia com suturas de quitosana ou poliglecaprone
Expression of EGF rececptors, cell cycle inhibitors and regulators in canine prostate with proliferative lesions
Submitted by Cássia Santos ([email protected]) on 2015-03-27T14:09:53Z
No. of bitstreams: 2
Tese - Mariana Batista Rodrigues Faleiro - 2014.pdf: 5818224 bytes, checksum: a60fa8936047debb466ca6014a330b87 (MD5)
license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5)Approved for entry into archive by Luciana Ferreira ([email protected]) on 2015-03-27T15:47:36Z (GMT) No. of bitstreams: 2
Tese - Mariana Batista Rodrigues Faleiro - 2014.pdf: 5818224 bytes, checksum: a60fa8936047debb466ca6014a330b87 (MD5)
license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5)Made available in DSpace on 2015-03-27T15:47:36Z (GMT). No. of bitstreams: 2
Tese - Mariana Batista Rodrigues Faleiro - 2014.pdf: 5818224 bytes, checksum: a60fa8936047debb466ca6014a330b87 (MD5)
license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5)
Previous issue date: 2014-11-14Conselho Nacional de Pesquisa e Desenvolvimento Científico e Tecnológico - CNPqSomedysplastic lesionsof prostate, such as proliferativeinflammatoryatrophy (PIA) and
prostatic intraepithelial neoplastic(PIN) are proliferative,consideredpremalignant andcan
progress toprostatic carcinoma (PC). Others, such asbenign prostatichyperplasia(BPH) are
proliferative, butare not related tomalignancy.The humanPC is the one ofcancers that more
kill,and dog`sthe onlyanimal species thatpresentsadiseasewith similarcharacteristics, thishas
been usedas a modelfor studyof prostatecancer. Thus, in order tobetter understandthe
molecular mechanisms involvedin repairand cell cycleevolution ofproliferative
lesionsincanine prostate, this study aimed to evaluatethe gene expression ofErbB1, ErbB2,
CDKN1A, CDKN1BandTP53andimmunostaining ofEGFR(Her1), Her2(c-erbB-2), p21,
p27and p53 inprostateswithPIAandPC. Also was evaluatedtheimmunostaining ofp21, p27,
p53, c-myc andcyclinD1inprostateswith BPH, PIA, PINandPC. For this purpose,wereobtained
from atissue microarray (TMA)block, 106samplesofcanineprostate tissue, which 15 normal,
16with BPH, 30 withPIA, 20 with PIN, and 25with CP. The RT-PCR andRT-qPCR
techniques wereused to evaluategene expression, as well as immunohistochemistrywas used
to determinetheimmunophenotypeofprostatic lesions. As forEGFRand Her2has beenobserved
that thesereceptorsactin canine lesions withPIA and with PCan importantaction ofHer2,
suggesting that theyare involvedin carcinogenesisandtumor development in canineprostate.
Regarding to cellcycleinhibitor concludethat whenoverexpressedin canine
prostateswithPIAandPC, p21andp27control cellproliferation, acting as a protective factorin
the evolution of PIA to PC, and in the PC development, even in the presence of altereted p53.
In assessing ofimmunostaining ofcell cycle regulators(p21, p27, p53, cyclinD1andc-myc) in
canineprostateswithproliferative lesionswas observedthatcarcinomas probably have
lowgrowth potentialwhenoverexpressed of p21andp27, reduced expression of cyclinD1and
unalteredexpression ofc-myc, even in the presence ofmutant p53type.Further,considering
thesimilarimmunophenotypein canine glands with PIA, PINandPC considered the
regulatorsofcell cycle progression, it is reinforce the pre-malignant potential of PIA andPINin
the canineprostate.Algumas lesões displásicas da próstata, como a atrofia inflamatória proliferativa (PIA) e a
neoplasia intraepitelial prostática (PIN), são proliferativas, consideradas pré-malignas e
podem evoluir para carcinoma prostático (PC). Outras, como a hiperplasia prostática benigna
(HPB), apesar de proliferativas, não possuem relação com malignidade. Sendo o PC humano
uma das neoplasias que mais matam, e o cão aúnica espécie animal que apresenta a
enfermidade com características semelhantes, esta tem sido utilizada como modelo para o
estudo do câncer de próstata. Assim, com o intuito de melhor compreender os mecanismos
moleculares envolvidos na regulação do ciclo celular e evolução das lesões proliferativas na
próstata canina, este estudo teve por objetivo avaliar a expressão gênica de ErbB1, ErbB2,
CDKN1A, CDKN1B e TP53,e imunomarcação deEGFR (Her1), Her2 (c-erbB-2), p21, p27 e
p53 em próstatas com PIA e PC. Também foi avaliada a imunomarcação de p21, p27, p53, cmyc
e cyclin D1 em próstatas com HPB, PIA, PIN e PC. Para tal, foram obtidas de um bloco
de microarranjo tecidual (TMA) 106 amostras de tecido prostático canino, sendo 15 normais,
16com HBP, 30com PIA, 20com PIN, e25com PC. As técnicas de RT-PCR e RT-qPCR
foram empregadas na avaliação da expressão gênica, assim como a técnica de
imunoistoquímica foi utilizada para verificar o imunofenótipo das lesões prostáticas. Quanto
aos receptores EGFReHer2 foi observado que esses atuam naslesões de PIAePCcanino, com
ação importante do receptor Her2, sugerindoqueessesestão envolvidosna carcinogênese e no
desenvolvimentotumoral da prostata canina.Em relação aos inibidores do ciclo celular
councluiu-se que quando superexpressos em próstatas com PIA e PC, p21 e p27 controlam a
proliferação celular, atuando comofator protetivo na evolução da PIA para PC, e no
desenvolviemento do PC, mesmo quando da alteração de p53. Na avaliação da
imunoexpressão dos reguladores do ciclo celular (p21, p27, p53, ciclina D1 e c-myc) em
próstatas caninas com lesões proliferativas foi constatado que os carcinomas possivelmente
apresentam baixo potencial de crescimento quando da superexpressãop21 ep27, menor
subexpressão de ciclina D1e expressão inalterada de c-myc, mesmo na presença de p53 tipo
mutante. Ainda, considerando o imunofenótipo semelhante nas glândulas com PIA, PIN e PC
no que se refere aos reguladores daprogressão do ciclo celular, reforça o potencial prémaligno
da PIA e PIN na próstata canina
Matrix metalloproteinases 2 and 9 expression in canine normal prostate and with proliferative disorders
Este estudo teve como objetivo avaliar a expressão das metaloproteinases 2 (MMP-2) e 9 (MMP-9) em próstatas caninas normais e com desordens proliferativas, verificando o papel dessas enzimas na remodelação da matriz extracelular (MEC) e no processo de invasão tecidual. Um total de 355 amostras prostáticas foram obtidas, sendo 36 (10,1%) normais, 46 (13,0%) com hiperplasia prostática benigna (HPB), 128 (36,1%) com atrofia inflamatória proliferativa (PIA), 74 (20,8%) com neoplasia intraepitelial prostática (PIN) e 71 (20,0%) com carcinoma prostático (CP). Houve diferença de imunomarcação citoplasmática para MMP-2 e MMP-9 entre o epitélio acinar e o estroma periacinar, quanto aos diferentes diagnósticos. Observou-se correlação entre a expressão de MMP-2 e MMP-9 em relação ao número de células marcadas no epitélio acinar e estroma periacinar, bem como para a intensidade de marcação das células estromais periacinares em próstatas caninas com PIA. Conclui-se que há variação na expressão de MMP-2 e MMP-9 em próstatas caninas de acordo com a lesão, com menor expressão em próstatas caninas normais e com HPB, e maior naquelas com PIA, PIN e CP. Ainda, o microambiente inflamatório na PIA influencia a atividade de ambas as enzimas.In this study the expression of metalloproteinases 2 (MMP-2) and 9 (MMP-9) in canine normal prostates and with proliferative disorders was evaluated to verify the role of these enzymes in extracellular matrix remodeling (ECM) and in the tissue invasion process. A total of 355 prostatic samples were obtained, from which 36 (10.1%) were normal prostates, 46 (13.0%) with benign prostatic hyperplasia (BPH), 128 (36.1%) with proliferative inflammatory atrophy (PIA), 74 (20.8%) with prostatic intraepithelial neoplasia (PIN), and 71 (20.0%) with prostatic carcinoma (PC). Difference in cytoplasmic immunohistochemical staining of MMP-2 and MMP-9 between acinar epithelium and periacinar stroma was found regarding the different diagnosis. The correlation between MMP-2 and MMP-9 expression in relation to the number of labeled cells in acinar epithelium and periacinar stroma, as well as to the staining intensity in the periacinar stromal cells was evidenced in canine prostates with PIA. In conclusion, MMP-2 and MMP-9 expression has a variation in canine prostate according to the lesion, with lower expression in normal tissue and with BPH, and higher expression in those with PIA, PIN and PC. Moreover, the inflammatory microenvironment of the PIA has influence in the activity of both enzymes
Matrix metalloproteinases 2 and 9 expression in canine normal prostate and with proliferative disorders Expressão de metaloproteinases de matriz 2 e 9 na próstata canina normal e com lesões proliferativas
In this study the expression of metalloproteinases 2 (MMP-2) and 9 (MMP-9) in canine normal prostates and with proliferative disorders was evaluated to verify the role of these enzymes in extracellular matrix remodeling (ECM) and in the tissue invasion process. A total of 355 prostatic samples were obtained, from which 36 (10.1%) were normal prostates, 46 (13.0%) with benign prostatic hyperplasia (BPH), 128 (36.1%) with proliferative inflammatory atrophy (PIA), 74 (20.8%) with prostatic intraepithelial neoplasia (PIN), and 71 (20.0%) with prostatic carcinoma (PC). Difference in cytoplasmic immunohistochemical staining of MMP-2 and MMP-9 between acinar epithelium and periacinar stroma was found regarding the different diagnosis. The correlation between MMP-2 and MMP-9 expression in relation to the number of labeled cells in acinar epithelium and periacinar stroma, as well as to the staining intensity in the periacinar stromal cells was evidenced in canine prostates with PIA. In conclusion, MMP-2 and MMP-9 expression has a variation in canine prostate according to the lesion, with lower expression in normal tissue and with BPH, and higher expression in those with PIA, PIN and PC. Moreover, the inflammatory microenvironment of the PIA has influence in the activity of both enzymes.<br>Este estudo teve como objetivo avaliar a expressão das metaloproteinases 2 (MMP-2) e 9 (MMP-9) em próstatas caninas normais e com desordens proliferativas, verificando o papel dessas enzimas na remodelação da matriz extracelular (MEC) e no processo de invasão tecidual. Um total de 355 amostras prostáticas foram obtidas, sendo 36 (10,1%) normais, 46 (13,0%) com hiperplasia prostática benigna (HPB), 128 (36,1%) com atrofia inflamatória proliferativa (PIA), 74 (20,8%) com neoplasia intraepitelial prostática (PIN) e 71 (20,0%) com carcinoma prostático (CP). Houve diferença de imunomarcação citoplasmática para MMP-2 e MMP-9 entre o epitélio acinar e o estroma periacinar, quanto aos diferentes diagnósticos. Observou-se correlação entre a expressão de MMP-2 e MMP-9 em relação ao número de células marcadas no epitélio acinar e estroma periacinar, bem como para a intensidade de marcação das células estromais periacinares em próstatas caninas com PIA. Conclui-se que há variação na expressão de MMP-2 e MMP-9 em próstatas caninas de acordo com a lesão, com menor expressão em próstatas caninas normais e com HPB, e maior naquelas com PIA, PIN e CP. Ainda, o microambiente inflamatório na PIA influencia a atividade de ambas as enzimas
uPAR EXPRESSION IN CANINE NORMAL PROSTATE AND WITH PROLIFERATIVE DISORDERS
Prostatic lesions such as prostatic intraepithelial neoplasia (PIN) and proliferative inflammatory atrophy (PIA) are studied in human and canine species due to their malignance potential. The plasminogen activator (PA) system has been suggested to play a central role in cell adhesion, angiogenesis, inflammation, and tumor invasion. The urokinase-type plasminogen activator receptor (uPAR) is a component of the PA, with a range of expression in tumor and stromal cells. In this study, uPAR expression in both canine normal prostates and with proliferative disorders (benign prostatic hyperplasia-BPH, proliferative inflammatory atrophy-PIA, prostatic intraepithelial neoplasia-PIN, and carcinoma-PC) was evaluated by immunohistochemistry in a tissue microarray (TMA) slide to establish the role of this enzyme in extracellular matrix (ECM) remodeling and in the processes of tissue invasion. A total of 298 cores and 355 diagnoses were obtained, with 36 (10.1%) normal prostates, 46 (13.0%) with BPH, 128 (36.1%) with PIA, 74 (20.8%) with PIN and 71 (20.0%) with PC. There is variation in the expression of uPAR in canine prostate according to the lesion, with lower expression in normal tissue and with BPH, and higher expression in tissue with PIA, PIN and PC. The high expression of uPAR in inflammatory and neoplastic microenvironment indicates increased proteolytic activity in canine prostates with PIA, PIN, and PC
Hystopathology and leishmania sp. immunostaining in third eyelid of leishmania (leishmania) chagasi naturally infected dogs
v. 16, n. 4, p. 538-547 out./dez. 2015.Submitted by Marlene Santos ([email protected]) on 2015-11-09T18:12:56Z
No. of bitstreams: 1
Artigo - Aline Maria Vasconcelos Lima - 2015.pdf: 1125837 bytes, checksum: 6c9bd1131d0fb07b2cfd2f952ef8a5f8 (MD5)Approved for entry into archive by Luciana Ferreira ([email protected]) on 2015-12-23T07:24:12Z (GMT) No. of bitstreams: 1
Artigo - Aline Maria Vasconcelos Lima - 2015.pdf: 1125837 bytes, checksum: 6c9bd1131d0fb07b2cfd2f952ef8a5f8 (MD5)Approved for entry into archive by Luciana Ferreira ([email protected]) on 2015-12-23T07:30:17Z (GMT) No. of bitstreams: 1
Artigo - Aline Maria Vasconcelos Lima - 2015.pdf: 1125837 bytes, checksum: 6c9bd1131d0fb07b2cfd2f952ef8a5f8 (MD5)Made available in DSpace on 2015-12-23T07:30:37Z (GMT). No. of bitstreams: 1
Artigo - Aline Maria Vasconcelos Lima - 2015.pdf: 1125837 bytes, checksum: 6c9bd1131d0fb07b2cfd2f952ef8a5f8 (MD5)
Previous issue date: 2015-08-14Programa de Apoio à Publicações Periódicas Científicas (PROAPUPEC) da UFG;CNPq; CAPESA leishmaniose visceral canina (LVC) é uma doença que envolve lesões multissistêmicas e, dentre os
vários tecidos acometidos, a terceira pálpebra está frequentemente envolvida. Este anexo ocular tem
sido alvo de estudo tanto para a elucidação da patogênese da doença quanto para o avanço diagnóstico.
O presente trabalho teve por objetivo avaliar as alterações histológicas presentes na terceira pálpebra
de cães naturalmente infectados por Leishmania chagasi e realizar a imunodetecção do parasita. Vinte
e seis amostras de terceira pálpebra de cães sintomáticos foram avaliadas quanto à coloração de HE
e à imunoistoquímica com soro de cão positivo para Leishmania sp. A principal alteração observada
na conjuntiva da terceira pálpebra foi infiltração inflamatória predominantemente linfoplasmocitária,
com células de Mott e histiócitos parasitados permeando a área de exsudação. Adicionalmente, perda
de estratificação e ulceração epitelial, rarefação ou hiperplasia de células caliciformes foram achados
costumazes. Na glândula lacrimal da terceira pálpebra, o mesmo padrão inflamatório foi observado,
acompanhado frequentemente de atrofia acinar e dilatação dos ductos secretórios. A imunoistoquímica
revelou parasitismo em todas as amostras, em diferentes intensidades.Canine visceral leishmaniasis (CVL) is a disease with multisystemic injuries, and among the various
tissues affected, the third eyelid (TE) is often involved. This ocular adnexa has been studied for the
leishmaniasis pathogenesis elucidation and for diagnosis advance. This study aimed to carry out the
parasite immunodetection and evaluate histologic lesions in TE of Leishmania (leishmania) chagasi
naturally infected dogs. Twenty-six TE samples from infected dogs were submitted to histologic
evaluation and to immunohistochemistry for Leishmania sp. The main lesion observed in the third
eyelid conjunctiva (TEC) was lymphoplasmacytic inflammation, with Mott cells and parasitized
histiocytes. Additionally, loss of epithelial stratification, ulceration, goblet cells thinning or hyperplasia
were often found. The same inflammatory pattern was observed in the third eyelid lacrimal gland
(TELG), often accompanied by acinar atrophy and secretory ducts dilatation. Immunohistochemistry revealed parasitism in all samples, in different intensities
Correlation between clinical findings, mast cell count and interleukin 31 immunostaining in the skin of dogs with atopic dermatitis
ABSTRACT: In this study the correlation between the clinical score, mast cell count and interleukin 31 (IL-31) immunostaining in the skin of dogs with atopic dermatitis was determined. A total of 31 dogs of different breeds, from one to eight years of age, were chosen for the study. The 20 females and 11 males were categorized based on the CADESI-4 system, as having discrete, moderate or marked atopic dermatitis. Skin samples were collected from the axillary and interdigital regions and stained with hematoxylin and eosin for cytohistomorphological analyses and toluidine blue to evaluate the mast cell counts, and immunohistochemistry for the IL-31 immunostaining. Animals revealing higher atopic dermatitis scores had greater numbers of mast cells and IL-31 immunolabeled cells. More numbers of cells immunolabeled for IL-31 were evident in the axillary skin compared with the interdigital skin in dogs having this condition. A correlation was identified between the clinical scores and mast cell numbers in the interdigital region, as well as between the clinical scores and number of cells immunolabeled for IL-31 in the axillary area. A correlation was also reported between the mast cell numbers and IL-31 immunolabeled cells only in the axillary skin, and none in the interdigital regions. It was thus concluded that the mast cells and IL-31 are involved in the pathogenesis of the canine atopic dermatitis (CAD), as well as lymphocytes and plasma cells. It was also observed that the higher the degree of clinical severity of the disease, the more the numbers of mast cells and IL-31 in the skin of those animals suffering from CAD, which implies the influence of these immunological constituents on the genesis of pruritus and disease progression